ArticleBMC pediatrics2025
Post-infectious irritable bowel syndrome in a paediatric population: first data in a Middle Eastern country.
Article in BMC pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Unveiling the viral dimension: The paediatric gut virome as a key modulator of gastrointestinal metabolic, and neurodevelopmental health.World journal of virology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAcute gastroenteritis (AGE) is the second most common cause of paediatric hospitalizations and mortality worldwide. The type of etiological agent determines its clinical severity. Interestingly, AGE has been shown as a risk factor for the development of post-infection irritable bowel syndrome (PI-IBS). In this study, we aimed to correlate the clinical severity of AGE for different infectious etiologies with the occurrence of PI-IBS in North Lebanese children and adolescents.
methodsA total of 219 patients admitted with gastrointestinal complaints, aged between four and 15 years, were enrolled in this study. For each patient, a stool sample was obtained for microbiological analysis. Data on demographic and socioeconomic characteristics, and clinical history were collected. AGE severity was evaluated using the Vesikari Clinical Severity Scoring System. The patients were then followed to assess the development of PI-IBS, using the Bristol stool form scale and the Rome IV diagnostic criteria.
resultsViral pathogens were the predominant etiological agents of AGE (26.9%), followed by parasites (8.2%), and Salmonella spp. (4.6%). Of all the pathogens identified in this study, rotavirus was the predominant infectious agent (25.1%) associated with severe AGE. Children with parasitic or bacterial AGE had significantly higher C-reactive protein (CRP) average levels (p = 0.009). Moreover, 29 patients (13.24%) met the Rome IV criteria for PI-IBS, with mixed bowel habits (IBS-M) (48.3%) as the most frequent subtype.
conclusionThis study provided novel preliminary data on the development of PI-IBS in Lebanese children and adolescents. Further studies are needed to explore the pathogenesis of PI-IBS and possible prevention strategies. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.